Douglas Elliman INC

Douglas Elliman Inc. announced the appointment of Justyn Feldman and Sanghyun Lee as Class III directors to its Board, effective July 10, 2026.

Douglas Elliman Inc. announced the results of its 2026 annual meeting of stockholders, including the election of directors and ratification of its independent auditor.

Douglas Elliman Inc. reported a Q1 2026 net loss of $16.3 million amid a challenging real estate market and year-over-year revenue decline.

Douglas Elliman Inc. has reached a $17.5 million settlement in the Strougo derivative litigation, subject to final court approval.

Douglas Elliman Inc. has dismissed Deloitte & Touche LLP as its independent auditor and appointed EisnerAmper LLP as its new auditor.

Douglas Elliman Inc. has amended employment agreements for its CFO and General Counsel, increasing salaries, bonuses, and enhancing severance packages.

Douglas Elliman Inc. reported a net loss of $16.3 million for the first quarter of 2026, with revenues declining 15% year-over-year due to lower brokerage commissions and the absence of property management income.

Douglas Elliman Inc. reported reduced net losses for Q3 and YTD 2025, driven by strategic divestitures and improved gross profit margins, despite a slight quarterly revenue dip.

Douglas Elliman Inc. reported a wider net loss in Q2 2025 due to a derivative fair value adjustment, despite year-to-date operational improvements and positive Adjusted EBITDA.

Douglas Elliman Inc. saw a significant reduction in its operating loss for Q1 2025, driven by increased revenues from commissions and brokerage income, particularly in the New York City and Florida markets.

Douglas Elliman's Q3 2024 results show a net loss, impacted by a litigation settlement and market conditions, alongside significant management changes.

Douglas Elliman's Q2 2024 results show a net loss of $1.664 million, influenced by market conditions and a significant litigation settlement.

Douglas Elliman Inc. reported a significant turnaround in 2025, achieving net income and positive operating income, driven by the strategic sale of its property management business and increased average transaction values.

Douglas Elliman Inc.'s 2024 10-K filing reveals a 1% increase in transactions despite a challenging residential real estate market, with strategic investments in PropTech and a focus on luxury markets.

Douglas Elliman Inc. has filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.

Douglas Elliman Inc.'s annual 10-K filing details the rights of common and preferred stock, anti-takeover measures, and corporate governance policies.

Douglas Elliman Inc. reports a restricted stock award granted to Director Richard Lampen, vesting in one year, subject to continued service.

Douglas Elliman Inc. reports a restricted stock award granted to Director Perry Weitz.

Douglas Elliman Inc. reports a restricted stock award granted to Director Mark Zeitchick, vesting in one year.

Douglas Elliman Inc. reports a restricted stock award granted to Director White Wilson, vesting in one year.

Douglas Elliman Inc. reports a restricted stock award granted to SVP, General Counsel, and Secretary Bradley Harris.

Douglas Elliman Inc. reports a significant restricted stock award granted to Executive Vice President, Treasurer and CFO, Kirkland J. Bryant III.

Douglas Elliman Inc. has filed a definitive proxy statement with the SEC.

Douglas Elliman Inc. will hold its annual meeting of stockholders virtually on June 25, 2025, to elect directors, ratify the appointment of Deloitte & Touche LLP, and conduct an advisory vote on executive compensation.

Douglas Elliman Inc. has filed a definitive proxy statement with the SEC.

Douglas Elliman Inc. will hold its annual stockholder meeting virtually on August 21, 2024, to vote on director elections, auditor ratification, executive compensation, and a proposal to declassify the Board of Directors.

BlackRock, Inc. has reported a beneficial ownership of 5.3% in Douglas Elliman Inc.'s common stock, totaling 4,725,524 shares, as detailed in a recent Schedule 13G filing.

Phillip Frost, M.D., Frost Gamma Investments Trust, and Patricia Frost have filed an amended Schedule 13G, disclosing their continued beneficial ownership of 8.6% of Douglas Elliman Inc.'s common stock as of January 1, 2025.